15-43600664-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_153700.2(STRC):​c.4863C>G​(p.Leu1621Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00212 in 1,612,422 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 5 hom., cov: 28)
Exomes 𝑓: 0.0019 ( 49 hom. )

Consequence

STRC
NM_153700.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.53

Publications

0 publications found
Variant links:
Genes affected
STRC (HGNC:16035): (stereocilin) This gene encodes a protein that is associated with the hair bundle of the sensory hair cells in the inner ear. The hair bundle is composed of stiff microvilli called stereocilia and is involved with mechanoreception of sound waves. This gene is part of a tandem duplication on chromosome 15; the second copy is a pseudogene. Mutations in this gene cause autosomal recessive non-syndromic deafness. [provided by RefSeq, Jul 2008]
CKMT1B (HGNC:1995): (creatine kinase, mitochondrial 1B) Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 15-43600664-G-C is Benign according to our data. Variant chr15-43600664-G-C is described in ClinVar as Benign. ClinVar VariationId is 165299.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0045 (684/151948) while in subpopulation SAS AF = 0.0217 (104/4796). AF 95% confidence interval is 0.0183. There are 5 homozygotes in GnomAd4. There are 328 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRCNM_153700.2 linkc.4863C>G p.Leu1621Leu synonymous_variant Exon 26 of 29 ENST00000450892.7 NP_714544.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRCENST00000450892.7 linkc.4863C>G p.Leu1621Leu synonymous_variant Exon 26 of 29 5 NM_153700.2 ENSP00000401513.2

Frequencies

GnomAD3 genomes
AF:
0.00452
AC:
686
AN:
151832
Hom.:
5
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0108
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00721
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0219
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00122
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00267
AC:
669
AN:
250786
AF XY:
0.00281
show subpopulations
Gnomad AFR exome
AF:
0.00921
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.00476
Gnomad EAS exome
AF:
0.000435
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00120
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00187
AC:
2737
AN:
1460474
Hom.:
49
Cov.:
34
AF XY:
0.00214
AC XY:
1558
AN XY:
726438
show subpopulations
African (AFR)
AF:
0.00831
AC:
276
AN:
33202
American (AMR)
AF:
0.000962
AC:
43
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00482
AC:
126
AN:
26132
East Asian (EAS)
AF:
0.000277
AC:
11
AN:
39688
South Asian (SAS)
AF:
0.0109
AC:
929
AN:
85456
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53404
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5752
European-Non Finnish (NFE)
AF:
0.00110
AC:
1226
AN:
1111842
Other (OTH)
AF:
0.00199
AC:
120
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
117
234
352
469
586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00450
AC:
684
AN:
151948
Hom.:
5
Cov.:
28
AF XY:
0.00442
AC XY:
328
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.0107
AC:
445
AN:
41398
American (AMR)
AF:
0.00138
AC:
21
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00721
AC:
25
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.0217
AC:
104
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00122
AC:
83
AN:
67952
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00120
Hom.:
0
EpiCase
AF:
0.00115
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STRC: BP4, BP7, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Oct 11, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1621Leu in Exon 26 of STRC: This variant is not expected to have clinical sig nificance because it has been observed in 0.5% (23/4410) of African American chr omosomes by the NHLBI Exome Sequencing Project, it does not alter an amino acid residue, and it is not located within the splice consensus sequence (http://evs. gs.washington.edu/EVS/; dbSNP rs139683375). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
2.0
DANN
Benign
0.68
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139683375; hg19: chr15-43892862; API